Clal Biotechnology Industries Ltd Cash Flow-to-Debt Ratio
Clal Biotechnology Industries Ltd cash flow-to-debt ratio. Clal Biotechnology Industries Ltd (CBI) has a Cash Flow-to-Debt Ratio of -0.05x as of June 2025, meaning its operating cash flow of ILA-1.06 Million could theoretically repay 0% of its total liabilities (ILA19.52 Million) in one year. Check CBI cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Clal Biotechnology Industries Ltd (2006–2024)
Cash flow-to-debt ratio of Clal Biotechnology Industries Ltd from 2006 to 2024. Historical debt coverage capacity for Clal Biotechnology Industries Ltd across 19 annual periods. Check CBI total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Clal Biotechnology Industries Ltd Cash Flow-to-Debt Ratio by Year (2006–2024)
Clal Biotechnology Industries Ltd cash flow-to-debt ratio by year from 2006 to 2024. Year-by-year debt coverage analysis for Clal Biotechnology Industries Ltd. For the full cash flow conversion analysis, see CBI cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.30x | ILA-6.48 Million | ILA21.52 Million | ▼ -30.7% |
| 2023 | -0.23x | ILA-8.51 Million | ILA36.98 Million | ▲ +85.3% |
| 2022 | -1.56x | ILA-59.04 Million | ILA37.79 Million | ▼ -302.7% |
| 2021 | -0.39x | ILA-41.33 Million | ILA106.55 Million | ▼ -17.0% |
| 2020 | -0.33x | ILA-33.23 Million | ILA100.24 Million | ▼ -246.1% |
| 2019 | 0.23x | ILA27.03 Million | ILA119.12 Million | ▲ +138.7% |
| 2018 | -0.59x | ILA-86.98 Million | ILA148.46 Million | ▼ -45.0% |
| 2017 | -0.40x | ILA-91.41 Million | ILA226.14 Million | ▼ -31.4% |
| 2016 | -0.31x | ILA-112.63 Million | ILA366.21 Million | ▲ +7.9% |
| 2015 | -0.33x | ILA-147.00 Million | ILA440.31 Million | ▼ -23.4% |
| 2014 | -0.27x | ILA-115.95 Million | ILA428.44 Million | ▲ +1.8% |
| 2013 | -0.28x | ILA-148.98 Million | ILA540.45 Million | ▼ -20.2% |
| 2012 | -0.23x | ILA-81.22 Million | ILA354.19 Million | ▲ +68.2% |
| 2011 | -0.72x | ILA-102.45 Million | ILA142.01 Million | ▲ +10.9% |
| 2010 | -0.81x | ILA-111.93 Million | ILA138.20 Million | ▼ -43.0% |
| 2009 | -0.57x | ILA-86.86 Million | ILA153.41 Million | ▼ -63.6% |
| 2008 | -0.35x | ILA-52.41 Million | ILA151.47 Million | ▲ +18.4% |
| 2007 | -0.42x | ILA-47.05 Million | ILA110.98 Million | ▲ +77.5% |
| 2006 | -1.88x | ILA-23.55 Million | ILA12.50 Million | — |